citalopram has been researched along with s 1743 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Henry, D; Mansfield, P; Tonkin, A | 1 |
| Akyol, L; Celikbilek, A; Celikbilek, M; Pirti, I | 1 |
| Lehmann, DF; Wojnowicz, S | 1 |
1 review(s) available for citalopram and s 1743
| Article | Year |
|---|---|
Single-enantiomer drugs: elegant science, disappointing effects.
Topics: Albuterol; Anti-Asthmatic Agents; Anti-Ulcer Agents; Antidepressive Agents, Second-Generation; Citalopram; Cost-Benefit Analysis; Esomeprazole; Gastroesophageal Reflux; Humans; Stereoisomerism | 2004 |
2 other study(ies) available for citalopram and s 1743
| Article | Year |
|---|---|
Esomeprazole-induced irritability.
Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Esomeprazole; Female; Gastritis; Gastroesophageal Reflux; Humans; Irritable Mood; Mood Disorders; Proton Pump Inhibitors | 2014 |
The Evergreening of Biopharmaceuticals: Time to Defoliate.
Topics: Asthma; Biopharmaceutics; Citalopram; Depressive Disorder, Major; Drug Industry; Esomeprazole; Humans; Levalbuterol; Marketing; Stereoisomerism | 2016 |